Antimicrobial resistance (AMR) is a major and rapidly growing global public health challenge. Responsible for more than 700,000 deaths a year, it poses a significant threat to achieving the Sustainable Development Goals (SDGs), in particular SDG 3, which aims to ensure healthy lives and promote wellbeing for all.


A not-for-profit R&D organization

The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit research and development (R&D) organization that addresses global public health needs by developing and delivering new or improved antibiotic treatments, while endeavouring to ensure their sustainable access.


Joint DNDi-WHO initiative

Initiated by the World Health Organization (WHO) and the Drugs for Neglected Disease initiative (DNDi) in May 2016, GARDP is an important element of WHO’s Global Action Plan on Antimicrobial Resistance that calls for new public-private partnerships to encourage R&D of new antimicrobial agents and diagnostics.

GARDP benefits from its unique parentage, drawing strength from both WHO’s mandate to drive the global response to antimicrobial resistance and set health priorities, and DNDi’s expertise in harnessing partnerships to build a pipeline for neglected diseases and deliver not-for-profit, needs-driven R&D.


Addressing global public health priorities

GARDP’s programmes – sexually-transmitted infections, neonatal sepsis, paediatric antibiotics, and antimicrobial memory recovery, evaluation and exploratory research – are designed to address global public health priorities. Each programme incorporates sustainable access and stewardship strategies to ensure treatments are affordable and available to all those who need them.



Partnerships are central to GARDP’s model, the Foundation has built and continues to build, strong and equitable partnerships with key stakeholders in the field of antibiotic development. This includes WHO, pharmaceutical and biotechnology companies, academia, governments, health authorities, philanthropic organisations, and civil society from across the world.